Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic... Ann Surg Oncol (2017) 24:2707–2711 DOI 10.1245/s10434-017-5869-4 O R I G IN AL ARTI CL E – GA STROIN TESTINA L O N C OLO G Y Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Oliver S. Eng, MD, Sinziana Dumitra, MD, MSc, Michael O’Leary, MD, Mark Wakabayashi, MD, Thanh H. Dellinger, MD, Ernest S. Han, MD, Stephen J. Lee, MD, I. Benjamin Paz, MD, Gagandeep Singh, MD, and Byrne Lee, MD Department of Surgery, City of Hope National Medical Center, Duarte, CA ABSTRACT delta base excess of greater than ?4.3 mmol/L at 48 h may Background. Base excess is important in assessing be an appropriate goal for resuscitation of CRS/HIPEC metabolic status. Postoperative management in patients patients in the immediate postoperative period. Standard- undergoing cytoreductive surgery (CRS) with hyperther- ized protocols to correct the base deficit in CRS/HIPEC mic intraperitoneal chemotherapy (HIPEC) for peritoneal patients during the early postoperative period can poten- malignancies can be a challenge, and we therefore sought tially help mitigate perioperative morbidity. to investigate perioperative predictors of overall morbidity in CRS/HIPEC patients at our institution. Cytoreductive surgery (CRS) with hyperthermic Methods. Patients who underwent CRS/HIPEC from 2012 to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Loading next page...
 
/lp/springer_journal/base-excess-as-a-predictor-of-complications-in-cytoreductive-surgery-UvCpH85vae
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-017-5869-4
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2017) 24:2707–2711 DOI 10.1245/s10434-017-5869-4 O R I G IN AL ARTI CL E – GA STROIN TESTINA L O N C OLO G Y Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Oliver S. Eng, MD, Sinziana Dumitra, MD, MSc, Michael O’Leary, MD, Mark Wakabayashi, MD, Thanh H. Dellinger, MD, Ernest S. Han, MD, Stephen J. Lee, MD, I. Benjamin Paz, MD, Gagandeep Singh, MD, and Byrne Lee, MD Department of Surgery, City of Hope National Medical Center, Duarte, CA ABSTRACT delta base excess of greater than ?4.3 mmol/L at 48 h may Background. Base excess is important in assessing be an appropriate goal for resuscitation of CRS/HIPEC metabolic status. Postoperative management in patients patients in the immediate postoperative period. Standard- undergoing cytoreductive surgery (CRS) with hyperther- ized protocols to correct the base deficit in CRS/HIPEC mic intraperitoneal chemotherapy (HIPEC) for peritoneal patients during the early postoperative period can poten- malignancies can be a challenge, and we therefore sought tially help mitigate perioperative morbidity. to investigate perioperative predictors of overall morbidity in CRS/HIPEC patients at our institution. Cytoreductive surgery (CRS) with hyperthermic Methods. Patients who underwent CRS/HIPEC from 2012 to

Journal

Annals of Surgical OncologySpringer Journals

Published: May 30, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off